» Articles » PMID: 25331710

Vitamin D Deficiency is Associated with Inflammatory Cytokine Concentrations in Patients with Diabetic Foot Infection

Overview
Journal Br J Nutr
Date 2014 Oct 22
PMID 25331710
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D has been recognised as a potent immunomodulator and its deficiency is common in different population groups including patients with diabetic foot infection. Diabetic foot infection reflects the altered immune status of the host. As cytokine regulation plays a significant role in infection and wound-healing processes, the present study aimed to evaluate the association between vitamin D status and inflammatory cytokine profiles in patients with diabetic foot infection. The serum concentrations of vitamin D (25-hydroxyvitamin D), IL-1β, IL-6, TNF-α and interferon-γ (IFN-γ) were measured in 112 diabetic foot infection cases and 109 diabetic controls. Severe vitamin D deficiency (25-hydroxyvitamin D concentration < 25 nmol/l) was more common in cases than in controls (48.2 v. 20.5%). Although age, duration of diabetes, HbA1C (glycosylated Hb) concentration and BMI were similar, cases had significantly higher concentrations of IL-6 (P≤ 0.001), IL-1β (P≤ 0.02) and TNF-α (P≤ 0.006) than controls. A significant negative correlation was also observed between 25-hydroxyvitamin D concentration and circulating concentrations of IL-1β (r -0.323; P≤ 0.001) as well as IL-6 (r -0.154; P≤ 0.04), but not between 25-hydroxyvitamin D and TNF-α and IFN-γ concentrations. Furthermore, a significant difference in IL-1β (P≤ 0.007) and IL-6 (P≤ 0.02) concentrations was observed in patients with severe 25-hydroxyvitamin D deficiency compared with patients with 25-hydroxyvitamin D concentration ≥ 25 nmol/l, and this difference was remarkable for TNF-α. In conclusion, severe vitamin D deficiency is associated with elevated inflammatory cytokine concentrations in diabetic patients, particularly in those with foot infection. A 25-hydroxyvitamin D concentration value < 25 nmol/l is suggested as the 'cut-off' for such immunological alterations in patients with diabetes mellitus.

Citing Articles

The role of vitamin D in diabetic foot ulcer; an umbrella review of meta-analyses.

Liu L, Zhang F, Jamali M, Guimaraes N, Radkhah N, Jamilian P Front Nutr. 2024; 11:1454779.

PMID: 39444578 PMC: 11497990. DOI: 10.3389/fnut.2024.1454779.


Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy.

Stoian A, Muntean C, Baba D, Manea A, Denes L, Simon-Szabo Z Int J Mol Sci. 2024; 25(19).

PMID: 39408723 PMC: 11476795. DOI: 10.3390/ijms251910395.


The correlation between serum vitamin D status and the occurrence of diabetic foot ulcers: a comprehensive systematic review and meta-analysis.

Tang W, Chen D, Chen L, Liu G, Sun S, Wang C Sci Rep. 2024; 14(1):21932.

PMID: 39304728 PMC: 11415517. DOI: 10.1038/s41598-024-73133-0.


Unlocking the potential of flavonoid-infused drug delivery systems for diabetic wound healing with a mechanistic exploration.

Chowdhury A, Mazumder P Inflammopharmacology. 2024; 32(5):2861-2896.

PMID: 39217278 DOI: 10.1007/s10787-024-01561-5.


Association of vitamin D status and vitamin D receptor polymorphism in diabetic foot ulcer patients: A prospective observational study in a South-Indian tertiary healthcare facility.

Kurian S, Baral T, Benson R, Munisamy M, Saravu K, Rodrigues G Int Wound J. 2024; 21(8):e70027.

PMID: 39140454 PMC: 11322992. DOI: 10.1111/iwj.70027.